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The aims of this study were to assess changes in physical function and quality of life with the Western 
Ontario and McMaster Universities Osteoarthritis Index (WOMAC) and the instrument of the Medical 
Outcomes Study SF-36 Health Survey (MOS SF-36), respectively, in patients undergoing hip and knee 
joint replacement surgery and to compare the responsiveness of these two outcome measures 1 year 
after surgery.  
 
Design  
One hundred and ninety-four patients with osteoarthritis (OA knee 108, OA hip 86) admitted to four 
hospitals in Sydney were followed over a period of 1 year at 3 monthly intervals.  
 
Results  
WOMAC measures improved significantly after 1 year for OA hip and OA knee: there was reduction 
in pain of 71% and 53%, reduction in stiffness of 55% and 43% and improvement in physical function 
of 68% and 43%, respectively. MOS SF-36 measures in those having hip surgery improved 
significantly for pain (222%), physical function (247%), physical role functioning (402%), general 
health (110%), vitality (143%), social functioning (169%) and mental health (114%). For those in the 
knee surgery group, significant improvement was seen for pain (175%), physical function (197%), 
physical role functioning (275%), vitality (125%) and social functioning (119%). The WOMAC was a 
more responsive measure than the MOS SF-36.  
 
Conclusion  
WOMAC and MOS SF-36 detect significant and clinically meaningful changes in outcome after hip 
and knee replacement. WOMAC requires a smaller sample size and is more responsive in the short 
term. For a follow-up longer than 6 months MOS SF-36 provides additional information. The 
improvement in outcomes following hip joint surgery were significantly greater than those following 
knee surgery.  
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Introduction  
Joint replacement has had a major impact on the management of osteoarthritis (OA). Economically it 
requires an important and increasing part of the health budget in every country where it has been 
investigated. In the U.S.A. more than 400 000 primary hip and knee arthroplasties are performed each 
year and the annual costs of these procedures were estimated to exceed US$ 10 billion1. In Australia 
AUS$ 13.5 million Commonwealth benefits were paid in the financial year 1997/98 for 17 000 hip and 
knee replacements (customized tables, Health Insurance Commission), compared to AUS$ 8.5 million 
in 1991/92 for 14 000 hip and knee replacements2. Expenditures on primary joint arthroplasty surgery 
will increase in the future with our aging population. 
In clinical research, outcome instruments are of major importance. They have to be valid, 
reliable and responsive to change. The Western Ontario and McMaster Universities Osteoarthritis 
Index (WOMAC) is a multidimensional, self-administered outcome measure, which has been 
developed by Bellamy3 for clinical trials in patients with hip or knee osteoarthritis. It probes for the 
dimensions of pain (5 items), stiffness (2 items) and physical function (17 items). It has been 
intensively validated4 and shown to be a valid, reliable and responsive instrument. The Medical 
Outcomes Study SF-36 Health Survey (MOS SF-36) is a self-administered, generic health-related 
quality of life instrument. 
It was developed in the Rand Health Insurance experiment from the Rand Health Insurance 
long form. Quality of life is assessed by 36 items across eight dimensions (physical functioning, 
role/physical functioning, bodily pain, general health, vitality, social functioning, role/ emotional 
functioning, mental health). It has been tested for its psychometric properties 5,6. It has not been 
specially designed for patients with OA but seems to be applicable to a broad spectrum of diseases. 
Compared to the WOMAC it is a more general instrument with the advantage of the ability to assess 
pain, physical function and quality of life, which are the most important outcomes in clinical trials with 
osteoarthritic patients. The WOMAC and the MOS SF-36 have been recommended as valid outcome 
measures in OA research at the OMERACT III conference7 and in the guidelines of the Osteoarthritis 
Research Society8 to allow standardization and comparability between studies. In this study we wanted 
to quantify outcome after hip and knee replacement using these two recommended measures, the 
WOMAC and the MOS SF-36, and compare them prospectively. We hypothesized that the WOMAC 
would be the more efficient instrument, being disease-specific. 
 
Method  
Study Population  
 
This study is part of an ongoing large prospective trial assessing costs of arthritis. Nine orthopedic 
surgeons in four hospitals in Sydney, Australia (St Vincent’s Public and Private Hospitals, the Centre 
for Bone and Joint Disease and Mater Misericordiae) provided operation waiting lists for total primary 
hip or knee joint replacement. Both privately insured and public (non-insured) patients were included. 
All patients with a diagnosis of OA and rheumatoid arthritis were eligible to enter the study. Waiting 
lists were checked fortnightly to monitor the continuing recruitment. Patients were asked by telephone 
to take part in the trial. In this paper only patients with OA were analysed. Most patients were visited at 
home by the research assistant for an interview after having signed a consent form, and were also seen 
on admission for surgery. Follow-up was by postal questionnaires or home visit if necessary. Follow-
up home visits were made to four hip replacement and eight knee replacement patients. For two of the 
hip patients and two of the knee patients reading English was a problem, so the questions were read out 
to these people by the interviewer. For the remainder, the questionnaires were self-administered and the 
research assistant provided assistance where necessary. 
 
Assessments  
Over a 12-month period the patients were mailed WOMAC and MOS SF-36 questionnaires at 3-
monthly intervals. This analysis includes the first 12-month period of follow-up. Shortly before the 
questionnaires were due back patients were reminded by telephone calls. In case of failure to respond 
the patients were again reminded by telephone. Returned questionnaires were checked for missing 
answers and clarified by telephone if necessary. To minimize the drop-out rate patients were informed 
about the study progress with quarterly newsletters and personal contacts such as birthday cards. 
 
Analysis  
Data were entered using Paradox software and then analysed using Statistical Package for Social 
Sciences (SPSS) for Windows version 6.0 program9. Both questionnaires were scored according to 
guidelines of their authors10,11. P-values ≤0.05 were considered significant. Parametric Students t-tests 
(independent and paired tests) were used to assess the significance of the mean differences before and 
after the operation, when scores were approximately normally distributed. The non-parametric test 
(Mann–Whitney U-Wilcoxon sum W test) was used for the samples that were not normally distributed. 
Normality of distribution was examined by standard diagnostic tests (Lillefors test, box plot, normal 
probability plot and histogram). The distribution of age, gender and duration of disease in the groups of 
hip and knee joint replacement were assessed by chi-squared tests (for the dichotomous variable, 
gender) and independent t-tests (for continuous variables). The change in the different domains was 
calculated as the difference of the pre-operative score to the follow-up score. The improvement in the 
hip replacement group compared to the knee replacement group was the comparison of the mean score 
difference of the preoperative score and the follow-up score between the hip and the knee replacement 
groups. These two comparative analyses used paired tests limiting the calculations to those people who 
completed both questionnaires at each time point. These calculations required multiple comparisons. 
Adaptation of the significance level was not performed. The comparison of the improvement in the hip 
and knee replacement groups was further assessed using multivariate analysis to allow for age, gender 
and OA duration as potential confounders. The models were created by backward stepwise selection. 
 The estimates of the comparative responsiveness of the two instruments were calculated with the relative 
efficiency (RE) using the following formula)12: 
  
This comparison is related to pain and physical function, the only two dimensions measured in both 
questionnaires. The MOS SF-36 scores on a 0–100 worst to best scale. The WOMAC scores on a 1–5 best to worst 





Baseline characteristics of patients* 
Characteristic   Hip replacement   Knee replacement   Entire surgical  
group (N=86)   group (N=108)   group (N=194) 
 
Age (years)†   65 (11.5)    72 (7.0)    69 (9.9) 
Duration of disease (years)‡  8.5 (9.4)    12.0 (11.9)   10 (11.1) 
Female proportion (%)  39    61    52 
 
 *Providing at least one pre-operative and one post-operative WOMAC questionnaire. 
 †Mean (standard deviation). 
 ‡Median (standard deviation). 
 
From 24 February 1994 to 1 July 1996, 376 patients with OA on the waiting lists for hip or knee joint 
replacement were eligible to take part in the study. Of these, 124 patients did not take part in the study 
for the following reasons: 49 patients could not be contacted in time, 27 were not interested, 18 felt too 
old or unwell, the English of 12 patients was too poor, seven patients could not be contacted at the 
address provided by the surgeon, five patients did not have a telephone to be contacted by, four patients 
found the study too confusing and the operation was cancelled in two patients. There was no difference 
in age, sex or type of operation between those who provided pre and post-operative questionnaires and 
those who did not take part in the study.   
 Two hundred and fifty-two patients started the study, corresponding to a response rate of 
67.3%. Thirty-six patients provided pre-operative questionnaires and withdrew before providing post-
operative questionnaires for the following reasons: two patients died, in seven patients the operation 
was cancelled, two patients moved from their address and left no forwarding details and 25 patients 
denied further participation in the study. These 36 patients (14.3%) did not differ regarding sex and 
type of joint replacement operation but were older compared to the 194 patients in the analysis (t= 
−2.506, P=0.013, mean age of patients lost to follow-up and participants: 70±9.9 years and 74±10.4 
years, respectively). Twenty-two patients started to provide pre-operative data but their first 
postoperative questionnaire was answered after 1 July 1996. For 194 patients (86 with OA of the hip 
and 108 with OA of the knee) at least one pre-operative and one postoperative WOMAC questionnaire 
was available. One hundred and seventy-three patients (73 with OA of the hip and 100 with OA of the 
knee) provided at least one preoperative and one post-operative MOS SF-36 questionnaire in addition 
to the WOMAC questionnaires. Ninety-one per cent of hip questionnaires were completed within 4 
weeks prior to surgery, another 1.2% up to 5 weeks and 7.8% were longer than 5 weeks. For the knee 
patients, 88% were completed within 4 weeks pre-surgery, another 4.5% within 5 weeks and 7.5% in 
excess of 5 weeks. Where questionnaires were completed in excess of 5 weeks prior to surgery, these 
people were sent questionnaires, but did not complete them immediately pre-operatively. The mean 
time to surgery from pre-operative evaluation was 14.9 days for knee replacement patients and 14.2 
days for hip replacement patients.   
 The overall cohort was followed for a total of 2031 person-months, with an average of 11 
months. For the hip group, the total follow-up was 891 person-months (average 11 months) and for the 
knee group 1140 person months in total (average 10 months).  
 
Study Population Characteristics  
The study population characteristics of age, duration of disease and gender distribution are listed in 
Table I. In general, the patients in the hip replacement group were younger (t-value= −5.27, 130 df, 
P<0.001) and had a shorter duration of their disease (z-value= −2.68, P=0.007) than those undergoing 
knee replacement surgery. Preoperatively all the domains in the WOMAC and the MOS SF-36 were 
comparable between the two surgical cohorts (WOMAC: pain P=0.19, stiffness P=0.99, physical 
function P=0.52; SF-36: physical function P=0.78, role physical function z= −1.69, pain P=0.46, 
general health P=0.16, vitality P=0.54, social function z= −1.86, role emotional function P=0.68, 
mental health P=0.98). Four in the hip group had their other hip replaced and three in the knee group 
had their other knee replaced in the 12-month follow-up period. Those who had another joint replaced 
did not differ significantly when WOMAC and SF-36 scores were compared with those who had no 
further joint replacement at the 12-month follow-up. There was a low number of hospitalizations for 
adverse events most probably related to the primary arthroplasty (3% hip and 13% knee). These 
included 10 knee patients requiring manipulation under anesthesia, three with an infection in the 
operated joint and one knee patient and three hip patients with thromboembolic complications. The 12-
month WOMAC and SF-36 measures showed a significant difference in WOMAC physical function 
only with those requiring readmission to hospital within 12 months of knee arthroplasty reporting 
worse function at 12-month follow-up. No significant differences were seen in the hip replacement 
group in WOMAC or SF-36 scores at 12 months between those requiring readmission and those who 
did not. In addition, four knee replacement patients reported they required hospitalization for arthritis-
related conditions not related to the primary replacement within the 12-month follow-up period (such 
as neck pain due to arthritis, removal of cartilage from other knee). These patients reported 
significantly worse WOMAC pain, stiffness and function at 12-month follow-up than all other knee 
replacement patients (which includes those who were admitted for another arthroplasty or for 
conditions likely to be related to their primary arthroplasty). No difference was seen in any scale of the 
SF-36.  
 
Improvement Over Time In The Hip Replacement Group According To WOMAC  
The improvement over time in the patient group undergoing hip replacement surgery is shown in Fig. 
1.   In the hip group there was a reduction in the mean scores of pain, stiffness and physical function as 
assessed by the WOMAC of about 50% in the first 3 follow-up months after the operation. This 
improvement continued up to 1 year, when the improvement in physical function and pain from 
baseline was more than 60%. The changes were statistically significant at 3, 6, 9 and 12 months for 
each of the WOMAC dimensions. 
 
Improvement Over Time In The Knee Replacement Group According To WOMAC 
The patients undergoing knee replacement surgery showed similar results (Fig. 2). The pre-operative 
scores for pain, stiffness and physical function as assessed by the WOMAC improved after operation. 
The improvement compared with baseline was statistically significant at 3, 6, 9 and 12 months. After 1 
year the reduction in pain and stiffness and the improvement in physical function was each about 50%, 
respectively. 




Fig. 1. WOMAC scores (means and standard deviations) in the patient group undergoing hip joint replacement 
surgery. *P<0.05. Lower scores indicate a better health state. Baseline N=86; 3 months N=82; 6 months N=64; 9 
months N=61; 12 months N=43. 
 
Knee Joint Replacement Group 
 
 
Fig. 2. WOMAC scores (means and standard deviations) in the patient group undergoing knee joint replacement 
surgery. *P<0.05. Lower scores indicate a better health state. Baseline N=108; 3 months N=101; 6 months N=84; 
9 months N=67; 12 months N=48. 
 
Table II 
Improvement in the hip replacement group compared to the knee replacement group according to WOMAC 
WOMAC domain         Mean differences (95% CI) between hip and knee change from baseline scores to post- 
        operative follow-up 
3 months   6 months   9 months   12 months 
N    Hips: 79   Hips: 62   Hips: 67   Hips: 42 
Knees: 101  Knees: 84   Knees: 59   Knees: 48 
Pain    −1.3 (−2.7,0.04)  −0.9 (−2.4,0.6)  −2.0 (−3.6,−0.5)*  −2.6 (−4.6,−0.6)* 
Stiffness    −0.9 (−1.5,−0.2)*  −0.8 (−1.4,−0.2)* −1.1 (−1.7,−0.5)* −0.8 (−1.6,0.1) 
Physical function   −4.3 (−8.7,0.0)*  −5.2 (−9.4,−0.9)*  −7.9 (−12.7,−3.0)*  −10.8 (−17.1,−4.5)* 
 
  *P<0.05. 
  A negative score means a greater improvement in the hip replacement group. 
  CI=Confidence intervals. 
 
Improvement In The Hip Replacement Group Compared To The Knee Replacement 
Group According To WOMAC 
The improvement in the hip joint replacement group compared to the knee joint replacement group is 
shown in Table II. The mean improvement in pain, stiffness and physical function between baseline 
and the follow-ups were more pronounced in patients who had undergone a hip replacement compared 
with patients who had knee joint replacement. Using univariate analysis the improvement was 
statistically significantly greater at all follow-ups regarding physical function, at follow-ups 9 and 12 
months regarding pain and at follow-ups 3 and 6 months regarding stiffness. Multivariate analysis 
adjusting for age, sex and duration of disease confirmed a greater improvement in outcome for hip 
surgery patients at 9 months follow-up (pain P=0.008, stiffness P=0.0001 and physical function 
P=0.001, respectively) and at 12 months follow-up (pain P=0.02, stiffness P=0.02 and physical 
function P=0.001, respectively).  
 
Improvement Over Time In The Hip Replacement Group According To MOS SF-36  
The improvement over time in patients undergoing hip joint replacement is presented in Fig. 3(a) and 
(b) (the domains of physical function, physical role function, bodily pain and general health and the 
domains of vitality, social function, emotional role function and mental health, respectively). In the hip 
replacement group all eight domains of the MOS SF-36 improved after the joint operation. The 
improvement in physical functioning, physical role functioning, pain, vitality, social functioning and 
mental health compared to baseline was statistically significant at 3, 6, 9 and 12 months. The 
improvement in general health was statistically significant at 9 and 12 months, whereas the 
improvement in emotional role functioning was statistically significant only at 9 months. The relative 
improvement after 1 year was most pronounced for physical functioning (247%) and physical role 
functioning (402%). These two latter dimensions showed statistically significant improvement also 
from 3–6 months. The quarterly improvement for pain, vitality, social functioning and mental health 
was statistically significant only for the first quarter postoperatively.  
 
Improvement Over Time In The Knee Replacement Group According To MOS SF-36  
Figure 4 (a) (physical function, physical role function, bodily pain and general health) and (b) (vitality, 
social function, emotional role function and mental health) present the improvement over time in those 
undergoing knee joint replacement surgery. In the knee replacement group all domains of the 
questionnaire improved post-operatively except general health, which was not influenced by the 
surgical intervention. The improvement in physical functioning and pain was statistically significant at 
every follow-up, whereas the improvement in physical role functioning, vitality and social functioning 
was significant from 6 months on. As in the hip group the relative improvement at one year was most 
pronounced for the physical functioning (197%) and the physical role functioning (275%).  
 
Improvement In The Hip Replacement Group Compared To The Knee Replacement Group 
According To MOS SF-36  
Table III shows the change in the outcome of patients undergoing hip joint replacement surgery 
compared to those undergoing knee joint replacement surgery. Compared with patients after knee joint 
replacement, patients in the hip replacement group had a greater improvement for all domains at all 
follow-ups except regarding emotional role functioning at 12 months as assessed by the MOS SF-36. In 
univariate and multivariate analysis the greater improvement was significant at most of the quarterly 
follow-ups regarding physical function, pain and vitality. Significantly greater improvement in the hip 
group regarding physical role functioning using univariate analysis was confirmed by multivariate 
analysis only at three months post-operatively, whereas the greater improvement in mental health in the 
hip group was significant at 9 and 12 months after adjusting for age, sex and OA duration.  
 
Relative Efficiency Of The Womac Compared To MOS SF-36  
The WOMAC had a greater relative efficiency for pain and physical function at all follow-ups except 
for physical function in the knee replacement group at 12 months, where both questionnaires are 
similarly efficient (Table IV).   
 








Fig. 3. (a) The MOS SF-36 scores of the domains physical function, physical role function, bodily pain and 
general health (means and standard deviations) in the patient group undergoing hip joint replacement surgery. 
*P<0.05. Higher scores indicate a better health state. Baseline N=73; 3 months N=71; 6 months N=57; 9 months 
N=54; 12 months N=53. (b) The MOS SF-36 scores of the domains vitality, social function, emotional role 
function and mental health (means and standard deviations) in the patient group undergoing hip joint replacement 
surgery. *P<0.05. Higher scores indicate a better health state. Baseline N=73; 3 months N=71; 6 months N=57; 9 
months N=54; 12 months N=53. 
 
 








Fig. 4. (a) The MOS SF-36 scores of the domains physical function, physical role function, bodily pain and 
general health (means and standard deviations) in the patient group undergoing knee joint replacement surgery. 
*P<0.05. Higher scores indicate a better health state. Baseline N=100; 3 months N=89; 6 months N=77; 9 months 
N=66; 12 months N=51. (b) The MOS SF-36 scores of the domains vitality, social function, emotional role 
function and mental health (means and standard deviations) in the patient group undergoing knee joint replacement 
surgery. *P<0.05. Higher scores indicate a better health state. Baseline N=100; 3 months N=89; 6 months N=77; 9 




Improvement in the hip replacement group compared to the knee replacement group according to SF-36 
SF-36 domain  Mean difference (95% CI) between hip and knee change from baseline score to post-operative follow up 
3 months   6 months   9 months   12 months 
N    Hips: 66   Hips: 52   Hips: 49   Hips: 42 
Knees: 88   Knees: 76   Knees: 63   Knees: 45 
Physical function   10.7 (3.6,17.8)*  4.3 (−3.6,12.2)  8.4 (−0.2,17.0)  11.9 (1.6,22.3)* 
Physical role function  17.3 (3.7,30.8)*  16.1 (0.5,31.7)*  17.0 (0.8,33.3)*  9.2 (−10.2,28.7) 
Bodily pain   12.3 (4.5,20.2)*  8.2 (−1.2,17.6)  18.4 (8.4,28.4)*  18.5 (7.1,30.0)* 
General health   6.2 (−0.5,12.9)  5.5 (−1.2,12.2)  10.9 (3.1,18.7)*  5.3 (−2.8,13.4) 
Vitality    7.8 (−0.5,16.1)  8.0 (0.2,15.9)*  16.6 (8.3,24.9)*  11.2 (2.2,20.2)* 
Social function   3.7 (−10.3,17.8)  3.9 (−8.5,16.3)  7.7 (−6.4,22.0)  9.5 (−5.2,24.3) 
Emotional role function  6.2 (−12.2,24.6)  0.5 (−18.5,19.6)  5.2 (−16.2,26.5)  −1.2 (−22.7,20.3) 
Mental health   3.8 (−2.3,9.9)  1.7 (−4.5,7.8)  8.2 (0.7,15.5)*  7.4 (−0.2,15.0) 
 
  *P<0.05. 
  A positive score means a greater improvement in the hip replacement group. 
  CI=Confidence intervals. 
 
The greater relative efficiency of the WOMAC decreased over time for both surgical groups regarding 
pain and physical function. The relative efficiency of the WOMAC was most pronounced for pain 
assessment in the knee joint replacement group. 
 
Discussion 
Eighty-six patients undergoing hip joint replacement and 108 patients undergoing knee joint 
replacement were assessed pre-operatively and at 3-monthly follow-up intervals post-operatively with 
WOMAC and MOS SF-36 questionnaires. 
 
As ascertained by the WOMAC both patient groups experienced significant improvement in pain, 
stiffness and physical function. After 1 year, pain was reduced to 29% and 47% of the pre-operative 
measures in the hip and knee group, respectively, stiffness was reduced to 45% and 57%, 
respectively and physical function increased by 68% and 43%, respectively. The greatest improvement 
was seen in both groups within the first 3 months post-operatively. After 3 months all measures 
continued to improve with the absolute values levelling off. A dramatic improvement by three months 
and smaller changes thereafter in these patients has been described previously13. 
 As assessed by the MOS SF-36 both patient groups improved at all domains except that the 
general health of patients after knee replacement remained unaltered. Again, the greatest improvement 
in patients undergoing hip or knee replacement was seen within the first 3 months post-operatively. It 
seems a paradox that patients’ perception of their general health was not influenced after knee 
replacement although significant changes in health status could be demonstrated. An unchanged 
general health status was seen previously in other 2-year follow-up studies looking at total hip and knee 




The relative efficiency for WOMAC vs MOS SF-36 
 
 
Follow-up           Pain               Physical Function 
(months)                  Hip         Knee                          Hip          Knee 
 
 
0–3    1.43  1.94   1.73  1.73 
0–6    1.54  1.92   1.40  1.17 
0–9    1.42  1.84   1.48  1.24 
0–12    1.13  1.74   0.99  1.30 
 
 
Relative efficiency >1 if WOMAC is the more responsive measure. 
 
This may be explained by the fact that even after a very successful operation pain and restrictions in 
daily life remain post-operatively, which are perceived by patients strongly enough to rate their general 
health as insufficient. Perhaps this paradox reflects some limitations of a generic health questionnaire 
which does not include other important aspects of quality of life, such as sleep and sexual function. 
Correlations between pain reduction and functional independence and psychological well-being have 
been shown by others to be inconsistent16. Although patients in the hip and the knee replacement group 
experienced improvement in virtually all domains after their operation, the improvement was earlier 
and more pronounced in patients with hip replacement for all domains of the WOMAC and for 
physical function, pain, general health, vitality and mental health assessed by the MOS SF-36. The 
reason for these differences is not clear, as there were no statistically significant differences in the 
outcome measures at baseline and using multivariate analysis potential confounders such as age, sex 
and duration of disease were adjusted for. Within this 1 year of follow-up no patient had to undergo a 
revision of the study knee or hip arthroplasty or a previously implanted hip or knee replacement. It is 
possible that these differences between hip and knee replacement groups could be explained by a 
different rate of post-operative complications, which were slightly higher in the knee group.  
 Comorbidities may also contribute; however, these were not assessed. A greater relative 
improvement in osteoarthritic hip vs knee replacement for pain and disability has been described 
elsewhere 17,18, including a 10-fold difference in Quality Adjusted Life Years (QALYs) gained 19 when 
hip replacement (4 QALYs gained) were compared to knee replacement (0.42 QALYs gained) 20. As a 
generic health status measure, the SF-36 has been found to be more relevant and more responsive than 
the Sickness Impact Profile and is the preferable generic health status measure in patients undergoing 
hip replacement 21. In this study the disease-specific WOMAC was a more responsive measure than the 
MOS SF-36. This was most pronounced in the assessment of pain in patients with knee the WOMAC 
regarding ascertainment of pain and physical function in both patient groups levelled somewhat 
compared to the first months of observations. This may be important for short-term studies with a 
duration of less than 1 year, where using the WOMAC questionnaire requires a smaller sample size. In 
agreement with the results of this study the WOMAC has been found to be the more sensitive measure 
in detecting knee disabilities compared to the MOS SF-36 22.  
This is not surprising, as the WOMAC has been developed as a specific outcome measure for 
patients with OA of the lower limb. Applying the MOS SF-36 questionnaire provided additional 
information on the patients’ quality of life as expressed by physical role functioning, general health, 
vitality, social functioning, emotional role functioning and mental health. This information is clinically 
important and patient-relevant, as well as the more traditional outcomes of pain, stiffness and physical 
function. Quality of life is a major determinant of the patients’ global assessment of satisfaction with 
their health status. Interestingly, quality of life was slower to improve after the operation and the 
relative changes were more subtle compared to the relative improvement in physical outcome 
measures. Similarly, a less dramatic improvement of psychological function compared to pain was 
noted in a cohort study of patients undergoing hip replacement surgery with a 6–8 week follow-up 23 
which may reflect a slower adaptation of psychological parameters compared to physical issues in a 
new life situation. The strengths of the study are its prospective design, high participation and follow-
up rate reducing well known sources of biases of retrospective and cross-sectional studies. The 
characteristics of the study population from multiple orthopedic surgeons and its source both in private 
and public hospitals should allow the generalizability of the results. Comparable results have been 
reported in American and British populations, but this is the first Australian study published 17,18,22.  
A further strength of this study is the high power of the analyses: the comparison of the 
WOMAC domains in both surgical groups had a power well over 80%. A similar power was calculated 
for physical function and bodily pain in the SF-36 questionnaire. Adjustment for age, sex and disease 
duration was performed in multiple regression analysis. In summary, WOMAC and MOS SF-36 detect 
significant and clinically meaningful changes in outcome after hip and knee replacement. We conclude 
that the WOMAC is a more responsive measure than the MOS SF-36, thus requiring a smaller sample 
size. This is important when designing short-term studies saving resources in time and money. In 
studies with a follow-up longer than 6 months MOS SF-36 provides useful additional information 
compared with using the WOMAC alone. For long-term studies it is useful to apply both the WOMAC 
and the MOS SF-36 questionnaires. After adjusting for age, gender and duration of OA the WOMAC 
outcomes of pain, stiffness and function and the SF-36 outcomes of pain, physical function, vitality and 
mental health following hip joint replacement surgery were greater than the improvement following 
knee joint replacement.  
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